Actively Recruiting
HeadStART: Evaluating the Effectiveness of Community ART Delivery for People Newly Diagnosed With HIV
Led by University of Washington · Updated on 2025-01-09
2720
Participants Needed
1
Research Sites
211 weeks
Total Duration
On this page
Sponsors
U
University of Washington
Lead Sponsor
N
National Institute of Mental Health (NIMH)
Collaborating Sponsor
AI-Summary
What this Trial Is About
This is a cluster randomized controlled trial at 12 health centers in refugee settlements in Uganda aiming to evaluate effectiveness of expansion of community antiretroviral therapy (ART) delivery to people newly diagnosed with HIV in achieving HIV viral suppression.
CONDITIONS
Official Title
HeadStART: Evaluating the Effectiveness of Community ART Delivery for People Newly Diagnosed With HIV
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Evidence of signed informed consent indicating understanding of the study
- Willingness and ability to comply with study visits, treatment plans, lab tests, and procedures
- Adults 18 years or older, or mature minors (14-17 years with drug/alcohol dependency or STI) or emancipated minors (under 18 who are pregnant, married, have a child, or self-sufficient)
- Tested HIV positive within the past 6 months and not already known to be HIV positive
- Able to communicate in Kiswahili, Runyankore, Kinyarwanda, Somali, or English
- For data abstraction only: adults 18 years or older, mature minors, or emancipated minors
- For data abstraction only: tested HIV positive in the past 6 months and not previously known to be HIV positive
You will not qualify if you...
- Pregnant and breastfeeding women
- Clients deemed by clinicians unfit for community-based care due to medical needs
- Concurrent enrollment in another biomedical clinical trial
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Infectious Diseases Institute, Makerere University
Kampala, Uganda
Actively Recruiting
Research Team
L
Layla Anderson
CONTACT
K
Kelli O'Laughlin, MD, MPH
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here